Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Sep;17(3):335-341.
doi: 10.1007/s11154-016-9366-z.

Hidradenitis suppurativa/Acne inversa: an endocrine skin disorder?

Affiliations
Review

Hidradenitis suppurativa/Acne inversa: an endocrine skin disorder?

Ioannis Karagiannidis et al. Rev Endocr Metab Disord. 2016 Sep.

Abstract

Hidradenitis suppurativa / acne inversa (HS) is a chronic inflammatory, debilitating skin disorder with a largely unknown etiology. However, many observations such as the typical onset of the disease after puberty, the female predominance, the pre-menstrual flare ups and the improvement during pregnancy suggest a contribution of endocrinological factors to the emergence of the disease. In addition, the reported efficacy of anti-androgen treatment on HS indicates a possible involvement of androgens in the pathogenesis. Furthermore, the common comorbidity with metabolic syndrome points to possible interactions between endocrinological and metabolic alterations in the development of HS. Taking into account the endocrine functions of the human skin, several studies investigated the effects of hormones and the behavior of the pilosebaceous unit in the skin of patients with HS. In this review we describe the current view on the hormonal dysregulation and metabolic syndrome and their role in HS.

Keywords: Acne inversa; Androgens; Apocrine glands; Diet; Endocrinology; Hidradenitis suppurativa; Hyperandrogenism; Menstruation; Metabolic syndrome; Obesity; Retinoids; Vitamin D.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Immunol. 2011 Jan 15;186(2):1228-39 - PubMed
    1. J Am Acad Dermatol. 2009 Jul;61(1):51-7 - PubMed
    1. Blood. 2007 May 1;109(9):3625-32 - PubMed
    1. J Clin Invest. 2007 Dec;117(12):3979-87 - PubMed
    1. Br J Dermatol. 2011 May;164(5):1017-22 - PubMed

LinkOut - more resources